Indoco Remedies Limited
↗Mumbai, India
Indoco Remedies Limited is a fully integrated, research-oriented pharmaceutical company based in India. It is engaged in the development, manufacturing, and marketing of finished dosage forms (FDFs) and active pharmaceutical ingredients (APIs), serving both domestic and international markets across more than 55 countries.
The company operates 11 manufacturing facilities—seven for finished dosages and four for APIs—supported by a state-of-the-art R&D center in Navi Mumbai and a dedicated Clinical Research Organization (CRO) facility, AnaCipher. Indoco's portfolio spans diverse therapeutic segments, including gastro-intestinal, respiratory, anti-infectives, stomatologicals, ophthalmics, nutritionals, cardiovascular, anti-diabetics, and pain management.
CLASSIFICATION
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$150M-$200M
Founded:1947
Ownership:public
Status:operating
FUNDING
Investors:SPA Holdings Pvt Ltd, Shanteri Investment Pvt Ltd, quant Money Managers Ltd
STOCK
Exchange:NSE|BSE
Ticker:INDOCO
Market Cap:$0.20B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Trial Phases:-
CORPORATE STRUCTURE
Subsidiaries:Indoco Remedies UK Limited, FPP Holding Company, LLC (85% stake)
Key Partnerships:Teva Pharmaceuticals (distribution), Caliber (Digital/Quality systems)
COMPETITION
Position:Niche Player
Competitors:Natco Pharma, Alembic Pharmaceuticals
LEADERSHIP
Key Executives:
Suresh G. Kare - Executive Chairman
Aditi Kare Panandikar - Managing Director
Sundeep V. Bambolkar - Jt. Managing Director
LINKS
Website:indoco.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Indoco Remedies Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Indoco Remedies Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.